

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * regulation of female receptivity (GO:0045924) | 7.21138180 |
| 2 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 6.35617323 |
| 3 | * female mating behavior (GO:0060180) | 6.33083838 |
| 4 | glutamate receptor signaling pathway (GO:0007215) | 5.83801615 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.24644779 |
| 6 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 5.15676215 |
| 7 | vocalization behavior (GO:0071625) | 5.12036923 |
| 8 | protein localization to synapse (GO:0035418) | 5.01004393 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.95521671 |
| 10 | synaptic transmission, glutamatergic (GO:0035249) | 4.88871039 |
| 11 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 4.84801132 |
| 12 | primary amino compound metabolic process (GO:1901160) | 4.83569239 |
| 13 | synapsis (GO:0007129) | 4.82714846 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.82344430 |
| 15 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.78989925 |
| 16 | serotonin metabolic process (GO:0042428) | 4.77119428 |
| 17 | neuron recognition (GO:0008038) | 4.69015393 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.64200437 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.62227590 |
| 20 | fat-soluble vitamin catabolic process (GO:0042363) | 4.61366408 |
| 21 | vitamin catabolic process (GO:0009111) | 4.61366408 |
| 22 | synaptic vesicle exocytosis (GO:0016079) | 4.61340462 |
| 23 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.58687923 |
| 24 | regulation of DNA endoreduplication (GO:0032875) | 4.47718359 |
| 25 | sensory perception of taste (GO:0050909) | 4.39915464 |
| 26 | behavioral fear response (GO:0001662) | 4.39670315 |
| 27 | behavioral defense response (GO:0002209) | 4.39670315 |
| 28 | * neuron-neuron synaptic transmission (GO:0007270) | 4.38629448 |
| 29 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.38489658 |
| 30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.36387482 |
| 31 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.26182229 |
| 32 | response to histamine (GO:0034776) | 4.25817397 |
| 33 | axonal fasciculation (GO:0007413) | 4.25077061 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.23391446 |
| 35 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.23259311 |
| 36 | detection of light stimulus involved in visual perception (GO:0050908) | 4.23259311 |
| 37 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.17623070 |
| 38 | long-term synaptic potentiation (GO:0060291) | 4.16329846 |
| 39 | positive regulation of synapse maturation (GO:0090129) | 4.14981998 |
| 40 | chromosome organization involved in meiosis (GO:0070192) | 4.13279390 |
| 41 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.12883855 |
| 42 | locomotory exploration behavior (GO:0035641) | 4.10366942 |
| 43 | fear response (GO:0042596) | 4.07488494 |
| 44 | inner ear receptor cell development (GO:0060119) | 4.07295359 |
| 45 | long-term memory (GO:0007616) | 4.05042009 |
| 46 | regulation of postsynaptic membrane potential (GO:0060078) | 4.04581879 |
| 47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.03626063 |
| 48 | regulation of glutamate secretion (GO:0014048) | 4.02451109 |
| 49 | membrane depolarization during action potential (GO:0086010) | 4.01810659 |
| 50 | exploration behavior (GO:0035640) | 4.01789483 |
| 51 | membrane repolarization during action potential (GO:0086011) | 4.01610890 |
| 52 | neuronal action potential (GO:0019228) | 4.00575754 |
| 53 | glutamate secretion (GO:0014047) | 3.99842018 |
| 54 | synaptonemal complex assembly (GO:0007130) | 3.99111609 |
| 55 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.98372204 |
| 56 | * regulation of synaptic plasticity (GO:0048167) | 3.96870691 |
| 57 | male meiosis I (GO:0007141) | 3.93348463 |
| 58 | innervation (GO:0060384) | 3.86433746 |
| 59 | DNA methylation involved in gamete generation (GO:0043046) | 3.83216533 |
| 60 | regulation of neuron projection regeneration (GO:0070570) | 3.82597021 |
| 61 | regulation of axon regeneration (GO:0048679) | 3.82597021 |
| 62 | coenzyme catabolic process (GO:0009109) | 3.80362587 |
| 63 | cochlea development (GO:0090102) | 3.80158422 |
| 64 | gamma-aminobutyric acid transport (GO:0015812) | 3.77866264 |
| 65 | positive regulation of dendritic spine development (GO:0060999) | 3.73014797 |
| 66 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.72761907 |
| 67 | dendritic spine organization (GO:0097061) | 3.67057329 |
| 68 | * transmission of nerve impulse (GO:0019226) | 3.64310398 |
| 69 | synaptonemal complex organization (GO:0070193) | 3.63068085 |
| 70 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.60866192 |
| 71 | cellular potassium ion homeostasis (GO:0030007) | 3.60726136 |
| 72 | negative regulation of appetite (GO:0032099) | 3.60338340 |
| 73 | negative regulation of response to food (GO:0032096) | 3.60338340 |
| 74 | synaptic vesicle endocytosis (GO:0048488) | 3.58448822 |
| 75 | regulation of dendritic spine development (GO:0060998) | 3.58102025 |
| 76 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.56125827 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 3.55393511 |
| 78 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.49816091 |
| 79 | sensory perception of chemical stimulus (GO:0007606) | 3.49219814 |
| 80 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.48902192 |
| 81 | presynaptic membrane assembly (GO:0097105) | 3.43525287 |
| 82 | regulation of synaptic vesicle transport (GO:1902803) | 3.43502364 |
| 83 | regulation of vesicle fusion (GO:0031338) | 3.43169388 |
| 84 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.41743991 |
| 85 | regulation of sensory perception of pain (GO:0051930) | 3.38621941 |
| 86 | regulation of sensory perception (GO:0051931) | 3.38621941 |
| 87 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.37341580 |
| 88 | piRNA metabolic process (GO:0034587) | 3.37161921 |
| 89 | kynurenine metabolic process (GO:0070189) | 3.36495501 |
| 90 | indole-containing compound metabolic process (GO:0042430) | 3.36095477 |
| 91 | positive regulation of membrane potential (GO:0045838) | 3.35179698 |
| 92 | dendritic spine morphogenesis (GO:0060997) | 3.33130116 |
| 93 | male meiosis (GO:0007140) | 3.30637712 |
| 94 | regulation of actin nucleation (GO:0051125) | 3.29676775 |
| 95 | regulation of synapse structural plasticity (GO:0051823) | 3.29203656 |
| 96 | membrane repolarization (GO:0086009) | 3.26294444 |
| 97 | presynaptic membrane organization (GO:0097090) | 3.26198309 |
| 98 | * learning (GO:0007612) | 3.26075696 |
| 99 | glycosphingolipid biosynthetic process (GO:0006688) | 3.23096633 |
| 100 | negative regulation of amino acid transport (GO:0051956) | 3.22933406 |
| 101 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.22477918 |
| 102 | meiosis I (GO:0007127) | 3.21490279 |
| 103 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.20510917 |
| 104 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.20151939 |
| 105 | membrane depolarization (GO:0051899) | 3.20060893 |
| 106 | regulation of Rac GTPase activity (GO:0032314) | 3.18620490 |
| 107 | postsynaptic membrane organization (GO:0001941) | 3.18253078 |
| 108 | regulation of gonadotropin secretion (GO:0032276) | 3.18073212 |
| 109 | regulation of synapse maturation (GO:0090128) | 3.16895009 |
| 110 | chemosensory behavior (GO:0007635) | 3.16124709 |
| 111 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.13233127 |
| 112 | sodium ion transmembrane transport (GO:0035725) | 3.12574613 |
| 113 | ephrin receptor signaling pathway (GO:0048013) | 3.12295519 |
| 114 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.10489192 |
| 115 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.10479674 |
| 116 | startle response (GO:0001964) | 3.10098400 |
| 117 | behavioral response to cocaine (GO:0048148) | 3.09300338 |
| 118 | detection of calcium ion (GO:0005513) | 3.08108368 |
| 119 | meiotic nuclear division (GO:0007126) | 3.07670694 |
| 120 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.07044356 |
| 121 | synaptic vesicle maturation (GO:0016188) | 3.06636129 |
| 122 | serotonin receptor signaling pathway (GO:0007210) | 3.05927724 |
| 123 | cAMP-mediated signaling (GO:0019933) | 3.05234072 |
| 124 | neurotransmitter secretion (GO:0007269) | 3.03062532 |
| 125 | positive regulation of response to oxidative stress (GO:1902884) | 3.01301255 |
| 126 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.01301255 |
| 127 | * multicellular organismal signaling (GO:0035637) | 3.00856460 |
| 128 | relaxation of smooth muscle (GO:0044557) | 3.00393286 |
| 129 | protein-chromophore linkage (GO:0018298) | 3.00365947 |
| 130 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.00052569 |
| 131 | negative regulation of cell killing (GO:0031342) | 3.00052569 |
| 132 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.99180948 |
| 133 | neuron remodeling (GO:0016322) | 2.98024944 |
| 134 | cell communication by electrical coupling (GO:0010644) | 2.96877872 |
| 135 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.96215921 |
| 136 | layer formation in cerebral cortex (GO:0021819) | 2.95929728 |
| 137 | * regulation of synaptic transmission (GO:0050804) | 2.95316578 |
| 138 | regulation of membrane repolarization (GO:0060306) | 2.93672703 |
| 139 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.93517615 |
| 140 | vesicle transport along microtubule (GO:0047496) | 2.93012655 |
| 141 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.92834702 |
| 142 | positive regulation of fibroblast migration (GO:0010763) | 2.92652047 |
| 143 | * synaptic transmission (GO:0007268) | 2.92189499 |
| 144 | proline transport (GO:0015824) | 2.91699810 |
| 145 | behavioral response to nicotine (GO:0035095) | 2.90235566 |
| 146 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.89368565 |
| 147 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.88706949 |
| 148 | Rac protein signal transduction (GO:0016601) | 2.88620175 |
| 149 | neuronal ion channel clustering (GO:0045161) | 2.88464156 |
| 150 | potassium ion export (GO:0071435) | 2.84158551 |
| 151 | cardiac conduction (GO:0061337) | 2.83171642 |
| 152 | action potential (GO:0001508) | 2.79567546 |
| 153 | positive regulation of growth hormone secretion (GO:0060124) | 2.79241651 |
| 154 | regulation of response to food (GO:0032095) | 2.79009930 |
| 155 | potassium ion import (GO:0010107) | 2.78862910 |
| 156 | meiotic chromosome segregation (GO:0045132) | 2.77269961 |
| 157 | regulation of cholesterol esterification (GO:0010872) | 2.77125125 |
| 158 | cGMP metabolic process (GO:0046068) | 2.75965738 |
| 159 | * multicellular organismal reproductive behavior (GO:0033057) | 2.75068979 |
| 160 | reciprocal meiotic recombination (GO:0007131) | 2.74240384 |
| 161 | reciprocal DNA recombination (GO:0035825) | 2.74240384 |
| 162 | acid secretion (GO:0046717) | 2.72712636 |
| 163 | NIK/NF-kappaB signaling (GO:0038061) | 2.72641525 |
| 164 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.71857777 |
| 165 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.71122683 |
| 166 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.68715868 |
| 167 | adult walking behavior (GO:0007628) | 2.68204834 |
| 168 | potassium ion transmembrane transport (GO:0071805) | 2.68103453 |
| 169 | cellular potassium ion transport (GO:0071804) | 2.68103453 |
| 170 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.65507425 |
| 171 | tryptophan catabolic process (GO:0006569) | 2.65119088 |
| 172 | indole-containing compound catabolic process (GO:0042436) | 2.65119088 |
| 173 | indolalkylamine catabolic process (GO:0046218) | 2.65119088 |
| 174 | otic vesicle formation (GO:0030916) | 2.64654329 |
| 175 | thyroid gland development (GO:0030878) | 2.62892308 |
| 176 | snRNA transcription (GO:0009301) | 2.61076084 |
| 177 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.61064777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.77844585 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.19054182 |
| 3 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.27608396 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.18569211 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.17330948 |
| 6 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.88305094 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70743061 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70743061 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.68696653 |
| 10 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58987337 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.52239041 |
| 12 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48502989 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47886464 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.44568399 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.43136281 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.38590125 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.34802451 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.33430543 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.32837841 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11168363 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.09816265 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08013901 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.07722456 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05653208 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.96002841 |
| 26 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.93475752 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.93239427 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93123706 |
| 29 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.92075136 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.86481078 |
| 31 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.84540464 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.84063901 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78776507 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.77987223 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75594258 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.75586369 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.75579251 |
| 38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75445761 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.72299687 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70856867 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66303406 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.63099918 |
| 43 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.58589562 |
| 44 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.55901658 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55659807 |
| 46 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54612392 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53807560 |
| 48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.48245256 |
| 49 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.47698722 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47297929 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47148480 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46866805 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46667411 |
| 54 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.46068140 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45372415 |
| 56 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.44145462 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43497457 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.41276970 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38658028 |
| 60 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38079364 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.37658255 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.35387101 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35257257 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34071055 |
| 65 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32704549 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32291544 |
| 67 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.32200354 |
| 68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30170962 |
| 69 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26191494 |
| 70 | JUN_21703547_ChIP-Seq_K562_Human | 1.25784683 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22010629 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21632600 |
| 73 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21009510 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17029558 |
| 75 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13977992 |
| 76 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13572859 |
| 77 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12853062 |
| 78 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12819344 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12237184 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11344416 |
| 81 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.10031290 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10023610 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09694440 |
| 84 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.09259892 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08491702 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08491702 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08409186 |
| 88 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08327449 |
| 89 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07764890 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07532535 |
| 91 | * AR_19668381_ChIP-Seq_PC3_Human | 1.06463831 |
| 92 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.05375283 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05043982 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04723896 |
| 95 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04246747 |
| 96 | NCOR_22424771_ChIP-Seq_293T_Human | 1.04139971 |
| 97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03387449 |
| 98 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03171823 |
| 99 | ERA_21632823_ChIP-Seq_H3396_Human | 1.02044302 |
| 100 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.01967630 |
| 101 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01352412 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01323151 |
| 103 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00997655 |
| 104 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99814721 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99809730 |
| 106 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99447028 |
| 107 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99309170 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98218375 |
| 109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98031436 |
| 110 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.97271139 |
| 111 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.97243288 |
| 112 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.95156314 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94712516 |
| 114 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94669260 |
| 115 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94625377 |
| 116 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94482304 |
| 117 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94297988 |
| 118 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.94163925 |
| 119 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.93904942 |
| 120 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.93727526 |
| 121 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93278644 |
| 122 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93206106 |
| 123 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92619921 |
| 124 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92533001 |
| 125 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92330776 |
| 126 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.91549973 |
| 127 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91154000 |
| 128 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.90855951 |
| 129 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90091169 |
| 130 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88778776 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88012419 |
| 132 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87274982 |
| 133 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.86584099 |
| 134 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86402688 |
| 135 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86402688 |
| 136 | P68_20966046_ChIP-Seq_HELA_Human | 0.86288087 |
| 137 | SA1_27219007_Chip-Seq_Bcells_Human | 0.84991680 |
| 138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84193172 |
| 139 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.83767053 |
| 140 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.82724282 |
| 141 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82670842 |
| 142 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82656746 |
| 143 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82481627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.88381930 |
| 2 | MP0003880_abnormal_central_pattern | 6.86361589 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.28871819 |
| 4 | MP0009745_abnormal_behavioral_response | 3.67945436 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.64677111 |
| 6 | MP0001986_abnormal_taste_sensitivity | 3.62466734 |
| 7 | MP0008004_abnormal_stomach_pH | 3.46098442 |
| 8 | MP0004270_analgesia | 3.23691455 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.22738792 |
| 10 | MP0002064_seizures | 3.15711263 |
| 11 | MP0002736_abnormal_nociception_after | 3.14503004 |
| 12 | MP0003136_yellow_coat_color | 3.04400621 |
| 13 | MP0002653_abnormal_ependyma_morphology | 2.97503797 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.96638862 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.96313184 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.81622671 |
| 17 | MP0002272_abnormal_nervous_system | 2.75884706 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.65278108 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.48361417 |
| 20 | MP0001486_abnormal_startle_reflex | 2.23156787 |
| 21 | MP0003329_amyloid_beta_deposits | 2.21976968 |
| 22 | MP0009046_muscle_twitch | 2.07748028 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.98530268 |
| 24 | MP0000778_abnormal_nervous_system | 1.96779464 |
| 25 | MP0002132_abnormal_respiratory_system | 1.93618880 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.93420884 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 1.93207973 |
| 28 | MP0001661_extended_life_span | 1.80316687 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.79359854 |
| 30 | MP0002184_abnormal_innervation | 1.76166418 |
| 31 | MP0003119_abnormal_digestive_system | 1.74920756 |
| 32 | MP0003283_abnormal_digestive_organ | 1.71696612 |
| 33 | MP0001970_abnormal_pain_threshold | 1.67353161 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.66801677 |
| 35 | MP0001529_abnormal_vocalization | 1.58392093 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.52633061 |
| 37 | MP0002822_catalepsy | 1.52306287 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.46441774 |
| 39 | MP0001905_abnormal_dopamine_level | 1.46419410 |
| 40 | MP0004924_abnormal_behavior | 1.45018776 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.45018776 |
| 42 | MP0002163_abnormal_gland_morphology | 1.40928353 |
| 43 | MP0003787_abnormal_imprinting | 1.39381128 |
| 44 | MP0003879_abnormal_hair_cell | 1.38219828 |
| 45 | * MP0006276_abnormal_autonomic_nervous | 1.38051217 |
| 46 | MP0002102_abnormal_ear_morphology | 1.35372552 |
| 47 | MP0006292_abnormal_olfactory_placode | 1.34505911 |
| 48 | MP0000955_abnormal_spinal_cord | 1.32253133 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.32165022 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.30904894 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.29261944 |
| 52 | MP0004484_altered_response_of | 1.28266744 |
| 53 | MP0001188_hyperpigmentation | 1.25585821 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.24885606 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.24661616 |
| 56 | MP0004885_abnormal_endolymph | 1.23978211 |
| 57 | MP0003718_maternal_effect | 1.23904623 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.23574634 |
| 59 | MP0004043_abnormal_pH_regulation | 1.23216184 |
| 60 | MP0005360_urolithiasis | 1.23146973 |
| 61 | MP0008569_lethality_at_weaning | 1.19566899 |
| 62 | MP0002160_abnormal_reproductive_system | 1.18340207 |
| 63 | MP0004858_abnormal_nervous_system | 1.16520946 |
| 64 | MP0003646_muscle_fatigue | 1.16371907 |
| 65 | MP0005409_darkened_coat_color | 1.16270163 |
| 66 | MP0000604_amyloidosis | 1.15813677 |
| 67 | MP0003633_abnormal_nervous_system | 1.12392371 |
| 68 | MP0004510_myositis | 1.11728377 |
| 69 | MP0010386_abnormal_urinary_bladder | 1.07775449 |
| 70 | MP0002210_abnormal_sex_determination | 1.07678989 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 1.06534690 |
| 72 | MP0000751_myopathy | 1.05227915 |
| 73 | MP0001984_abnormal_olfaction | 1.02972577 |
| 74 | MP0008874_decreased_physiological_sensi | 1.01615882 |
| 75 | MP0002152_abnormal_brain_morphology | 1.01608365 |
| 76 | MP0009840_abnormal_foam_cell | 1.01595950 |
| 77 | MP0003631_nervous_system_phenotype | 0.98722083 |
| 78 | MP0004142_abnormal_muscle_tone | 0.98430620 |
| 79 | MP0000372_irregular_coat_pigmentation | 0.97424561 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 0.97161104 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.95782656 |
| 82 | MP0009379_abnormal_foot_pigmentation | 0.95437694 |
| 83 | MP0004215_abnormal_myocardial_fiber | 0.94112908 |
| 84 | MP0004147_increased_porphyrin_level | 0.91976041 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.91888160 |
| 86 | MP0002229_neurodegeneration | 0.89148390 |
| 87 | MP0004130_abnormal_muscle_cell | 0.87659229 |
| 88 | MP0004085_abnormal_heartbeat | 0.85679492 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.85664367 |
| 90 | MP0002069_abnormal_eating/drinking_beha | 0.85610137 |
| 91 | MP0003938_abnormal_ear_development | 0.85343326 |
| 92 | MP0003698_abnormal_male_reproductive | 0.85147388 |
| 93 | MP0005535_abnormal_body_temperature | 0.84956373 |
| 94 | MP0000538_abnormal_urinary_bladder | 0.84164117 |
| 95 | MP0005171_absent_coat_pigmentation | 0.83610612 |
| 96 | MP0002234_abnormal_pharynx_morphology | 0.82324858 |
| 97 | MP0003638_abnormal_response/metabolism_ | 0.81761333 |
| 98 | MP0003075_altered_response_to | 0.81117746 |
| 99 | MP0000678_abnormal_parathyroid_gland | 0.80601686 |
| 100 | MP0004742_abnormal_vestibular_system | 0.79273879 |
| 101 | MP0008872_abnormal_physiological_respon | 0.78520409 |
| 102 | MP0001177_atelectasis | 0.77562646 |
| 103 | MP0001664_abnormal_digestion | 0.76766556 |
| 104 | MP0000026_abnormal_inner_ear | 0.75226444 |
| 105 | MP0003122_maternal_imprinting | 0.74927553 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.73499825 |
| 107 | MP0002752_abnormal_somatic_nervous | 0.73052860 |
| 108 | MP0005499_abnormal_olfactory_system | 0.71126015 |
| 109 | MP0005394_taste/olfaction_phenotype | 0.71126015 |
| 110 | MP0005595_abnormal_vascular_smooth | 0.70937585 |
| 111 | * MP0002909_abnormal_adrenal_gland | 0.69704696 |
| 112 | MP0003121_genomic_imprinting | 0.68784822 |
| 113 | MP0009697_abnormal_copulation | 0.68586547 |
| 114 | MP0003123_paternal_imprinting | 0.67669178 |
| 115 | MP0000653_abnormal_sex_gland | 0.67448994 |
| 116 | MP0001929_abnormal_gametogenesis | 0.67183842 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.67086074 |
| 118 | MP0008789_abnormal_olfactory_epithelium | 0.64983504 |
| 119 | MP0009384_cardiac_valve_regurgitation | 0.63832764 |
| 120 | MP0002090_abnormal_vision | 0.63785428 |
| 121 | MP0003632_abnormal_nervous_system | 0.63673046 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.62985287 |
| 123 | MP0000631_abnormal_neuroendocrine_gland | 0.62842378 |
| 124 | MP0001145_abnormal_male_reproductive | 0.62705765 |
| 125 | * MP0000230_abnormal_systemic_arterial | 0.62413375 |
| 126 | MP0003634_abnormal_glial_cell | 0.61843707 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.61503785 |
| 128 | MP0005187_abnormal_penis_morphology | 0.60999141 |
| 129 | MP0005389_reproductive_system_phenotype | 0.60670437 |
| 130 | MP0010329_abnormal_lipoprotein_level | 0.60433992 |
| 131 | MP0004019_abnormal_vitamin_homeostasis | 0.59548851 |
| 132 | MP0003690_abnormal_glial_cell | 0.59020085 |
| 133 | MP0005623_abnormal_meninges_morphology | 0.56410693 |
| 134 | MP0006072_abnormal_retinal_apoptosis | 0.54123990 |
| 135 | MP0003861_abnormal_nervous_system | 0.51700711 |
| 136 | MP0005620_abnormal_muscle_contractility | 0.50709045 |
| 137 | MP0000920_abnormal_myelination | 0.50550922 |
| 138 | MP0005410_abnormal_fertilization | 0.50383516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.64419031 |
| 2 | Focal seizures (HP:0007359) | 6.05501737 |
| 3 | Atonic seizures (HP:0010819) | 5.74025259 |
| 4 | Visual hallucinations (HP:0002367) | 5.71335556 |
| 5 | Absence seizures (HP:0002121) | 5.27726933 |
| 6 | Epileptic encephalopathy (HP:0200134) | 5.21217757 |
| 7 | Myokymia (HP:0002411) | 5.13531673 |
| 8 | Hyperventilation (HP:0002883) | 5.13364131 |
| 9 | Dialeptic seizures (HP:0011146) | 5.05550464 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 5.00194480 |
| 11 | Febrile seizures (HP:0002373) | 4.97740521 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.22611327 |
| 13 | Cerebral hypomyelination (HP:0006808) | 4.21769162 |
| 14 | Abnormality of cochlea (HP:0000375) | 4.07789936 |
| 15 | Severe visual impairment (HP:0001141) | 3.99218498 |
| 16 | Tinnitus (HP:0000360) | 3.97752272 |
| 17 | Amblyopia (HP:0000646) | 3.94768137 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.92868661 |
| 19 | Broad-based gait (HP:0002136) | 3.67637060 |
| 20 | Drooling (HP:0002307) | 3.54971291 |
| 21 | Excessive salivation (HP:0003781) | 3.54971291 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.52340611 |
| 23 | Spontaneous abortion (HP:0005268) | 3.43255256 |
| 24 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.40846477 |
| 25 | Progressive cerebellar ataxia (HP:0002073) | 3.39199532 |
| 26 | Gonadotropin excess (HP:0000837) | 3.37890999 |
| 27 | Decreased central vision (HP:0007663) | 3.37038421 |
| 28 | Delusions (HP:0000746) | 3.34441354 |
| 29 | Abnormality of the lower motor neuron (HP:0002366) | 3.33506746 |
| 30 | Dysmetria (HP:0001310) | 3.26976134 |
| 31 | Abolished electroretinogram (ERG) (HP:0000550) | 3.25037990 |
| 32 | Ventricular fibrillation (HP:0001663) | 3.21589358 |
| 33 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.13652742 |
| 34 | Congenital stationary night blindness (HP:0007642) | 3.09980625 |
| 35 | Tubular atrophy (HP:0000092) | 3.09155191 |
| 36 | Morphological abnormality of the inner ear (HP:0011390) | 3.08497549 |
| 37 | Testicular atrophy (HP:0000029) | 3.05581441 |
| 38 | Diplopia (HP:0000651) | 3.03778732 |
| 39 | Abnormality of binocular vision (HP:0011514) | 3.03778732 |
| 40 | Hemiparesis (HP:0001269) | 3.01600884 |
| 41 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.99837009 |
| 42 | Epileptiform EEG discharges (HP:0011182) | 2.96068715 |
| 43 | Truncal ataxia (HP:0002078) | 2.94524432 |
| 44 | CNS hypomyelination (HP:0003429) | 2.91945415 |
| 45 | Protruding tongue (HP:0010808) | 2.90498619 |
| 46 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.89111795 |
| 47 | Metabolic alkalosis (HP:0200114) | 2.88867723 |
| 48 | 11 pairs of ribs (HP:0000878) | 2.85995661 |
| 49 | Absent speech (HP:0001344) | 2.84856167 |
| 50 | Anxiety (HP:0000739) | 2.79007145 |
| 51 | Attenuation of retinal blood vessels (HP:0007843) | 2.72956700 |
| 52 | Concave nail (HP:0001598) | 2.72529769 |
| 53 | Dysdiadochokinesis (HP:0002075) | 2.71621658 |
| 54 | Scanning speech (HP:0002168) | 2.68967971 |
| 55 | Poor eye contact (HP:0000817) | 2.68879919 |
| 56 | Failure to thrive in infancy (HP:0001531) | 2.65120168 |
| 57 | True hermaphroditism (HP:0010459) | 2.57451538 |
| 58 | Congenital malformation of the right heart (HP:0011723) | 2.55859496 |
| 59 | Double outlet right ventricle (HP:0001719) | 2.55859496 |
| 60 | Hydroureter (HP:0000072) | 2.55539616 |
| 61 | Generalized myoclonic seizures (HP:0002123) | 2.55456239 |
| 62 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.51992901 |
| 63 | Abnormality of salivation (HP:0100755) | 2.51902950 |
| 64 | Progressive inability to walk (HP:0002505) | 2.51465136 |
| 65 | Status epilepticus (HP:0002133) | 2.49508098 |
| 66 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.44265857 |
| 67 | Thickened helices (HP:0000391) | 2.43645389 |
| 68 | Oligodactyly (hands) (HP:0001180) | 2.43495426 |
| 69 | Impaired smooth pursuit (HP:0007772) | 2.42484288 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.40204154 |
| 71 | Prominent supraorbital ridges (HP:0000336) | 2.39872683 |
| 72 | Gaze-evoked nystagmus (HP:0000640) | 2.39611887 |
| 73 | Inability to walk (HP:0002540) | 2.37027567 |
| 74 | Abnormal biliary tract physiology (HP:0012439) | 2.36473637 |
| 75 | Bile duct proliferation (HP:0001408) | 2.36473637 |
| 76 | Global brain atrophy (HP:0002283) | 2.35892887 |
| 77 | Abnormal social behavior (HP:0012433) | 2.34537712 |
| 78 | Impaired social interactions (HP:0000735) | 2.34537712 |
| 79 | Pigmentary retinal degeneration (HP:0001146) | 2.32049693 |
| 80 | Rapidly progressive (HP:0003678) | 2.30786106 |
| 81 | Action tremor (HP:0002345) | 2.29285414 |
| 82 | Acute necrotizing encephalopathy (HP:0006965) | 2.28090655 |
| 83 | Retinal dysplasia (HP:0007973) | 2.27736050 |
| 84 | Shoulder girdle muscle weakness (HP:0003547) | 2.25911513 |
| 85 | Depression (HP:0000716) | 2.24955396 |
| 86 | Mesangial abnormality (HP:0001966) | 2.23566786 |
| 87 | Short tibia (HP:0005736) | 2.23471579 |
| 88 | Psychosis (HP:0000709) | 2.16930980 |
| 89 | Horizontal nystagmus (HP:0000666) | 2.14518596 |
| 90 | Constricted visual fields (HP:0001133) | 2.13728051 |
| 91 | Dysautonomia (HP:0002459) | 2.11017030 |
| 92 | Stereotypic behavior (HP:0000733) | 2.10754426 |
| 93 | Palpebral edema (HP:0100540) | 2.10055804 |
| 94 | Fair hair (HP:0002286) | 2.09647108 |
| 95 | Amyotrophic lateral sclerosis (HP:0007354) | 2.09277953 |
| 96 | Widely spaced teeth (HP:0000687) | 2.08142496 |
| 97 | Congenital sensorineural hearing impairment (HP:0008527) | 2.07447968 |
| 98 | Pancreatic fibrosis (HP:0100732) | 2.07447896 |
| 99 | Sensory axonal neuropathy (HP:0003390) | 2.07388386 |
| 100 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.07048154 |
| 101 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.07048154 |
| 102 | Papilledema (HP:0001085) | 2.07047390 |
| 103 | Hypoplasia of the radius (HP:0002984) | 2.06898616 |
| 104 | Goiter (HP:0000853) | 2.06413369 |
| 105 | Blue irides (HP:0000635) | 2.06354167 |
| 106 | Hypsarrhythmia (HP:0002521) | 2.05944737 |
| 107 | Follicular hyperkeratosis (HP:0007502) | 2.05108730 |
| 108 | Progressive macrocephaly (HP:0004481) | 2.05060599 |
| 109 | Abnormality of renin-angiotensin system (HP:0000847) | 2.05017397 |
| 110 | Confusion (HP:0001289) | 2.04263268 |
| 111 | Retinitis pigmentosa (HP:0000510) | 2.04239269 |
| 112 | Prolonged QT interval (HP:0001657) | 2.02775462 |
| 113 | Decreased circulating renin level (HP:0003351) | 2.02487542 |
| 114 | Conical tooth (HP:0000698) | 2.01850791 |
| 115 | Retinal atrophy (HP:0001105) | 1.99247003 |
| 116 | Fibular hypoplasia (HP:0003038) | 1.98626746 |
| 117 | Syncope (HP:0001279) | 1.95746764 |
| 118 | Absent eyebrow (HP:0002223) | 1.95594056 |
| 119 | Absent phalangeal crease (HP:0006109) | 1.95061568 |
| 120 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.92401119 |
| 121 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.90755931 |
| 122 | Absent/shortened dynein arms (HP:0200106) | 1.90755931 |
| 123 | Rimmed vacuoles (HP:0003805) | 1.89718928 |
| 124 | Intention tremor (HP:0002080) | 1.89346898 |
| 125 | Bradykinesia (HP:0002067) | 1.88533007 |
| 126 | Spastic gait (HP:0002064) | 1.88013776 |
| 127 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.87834573 |
| 128 | Unsteady gait (HP:0002317) | 1.86748851 |
| 129 | Heterochromia iridis (HP:0001100) | 1.86550027 |
| 130 | Clumsiness (HP:0002312) | 1.85751049 |
| 131 | Generalized hypopigmentation of hair (HP:0011358) | 1.84725326 |
| 132 | Delayed CNS myelination (HP:0002188) | 1.84137390 |
| 133 | Abnormal ciliary motility (HP:0012262) | 1.83466415 |
| 134 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83063155 |
| 135 | Abnormality of alanine metabolism (HP:0010916) | 1.83063155 |
| 136 | Hyperalaninemia (HP:0003348) | 1.83063155 |
| 137 | Deep palmar crease (HP:0006191) | 1.82681333 |
| 138 | Abnormal eating behavior (HP:0100738) | 1.81966688 |
| 139 | Fetal akinesia sequence (HP:0001989) | 1.81436631 |
| 140 | Nephronophthisis (HP:0000090) | 1.80930597 |
| 141 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.80799969 |
| 142 | Hypoplasia of the ulna (HP:0003022) | 1.80220420 |
| 143 | Gait imbalance (HP:0002141) | 1.78819261 |
| 144 | Exotropia (HP:0000577) | 1.78761392 |
| 145 | Incomplete penetrance (HP:0003829) | 1.77369197 |
| 146 | X-linked dominant inheritance (HP:0001423) | 1.77032105 |
| 147 | Mutism (HP:0002300) | 1.76818225 |
| 148 | Type II lissencephaly (HP:0007260) | 1.75527752 |
| 149 | Mitochondrial inheritance (HP:0001427) | 1.75235118 |
| 150 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.75202974 |
| 151 | Aqueductal stenosis (HP:0002410) | 1.74021099 |
| 152 | Male pseudohermaphroditism (HP:0000037) | 1.73903970 |
| 153 | Pancreatic cysts (HP:0001737) | 1.73247705 |
| 154 | Gait ataxia (HP:0002066) | 1.72653137 |
| 155 | Choroideremia (HP:0001139) | 1.71597566 |
| 156 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.70970378 |
| 157 | Postural instability (HP:0002172) | 1.70935597 |
| 158 | Genetic anticipation (HP:0003743) | 1.70772178 |
| 159 | Increased circulating renin level (HP:0000848) | 1.70232229 |
| 160 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.69779800 |
| 161 | Inappropriate behavior (HP:0000719) | 1.69180161 |
| 162 | Urinary urgency (HP:0000012) | 1.68895668 |
| 163 | Poor suck (HP:0002033) | 1.68603641 |
| 164 | Insidious onset (HP:0003587) | 1.68268901 |
| 165 | Termporal pattern (HP:0011008) | 1.68268901 |
| 166 | Ankle clonus (HP:0011448) | 1.67591269 |
| 167 | Lower limb asymmetry (HP:0100559) | 1.67566779 |
| 168 | Impaired pain sensation (HP:0007328) | 1.66912921 |
| 169 | Abnormality of pain sensation (HP:0010832) | 1.66912921 |
| 170 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.65433199 |
| 171 | Abnormal finger flexion creases (HP:0006143) | 1.64723499 |
| 172 | Congenital primary aphakia (HP:0007707) | 1.61600037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.41115856 |
| 2 | RIPK4 | 5.31531928 |
| 3 | FRK | 4.91205487 |
| 4 | NTRK3 | 4.85755006 |
| 5 | TEC | 2.70391738 |
| 6 | PDK2 | 2.65289945 |
| 7 | MAP3K9 | 2.63537149 |
| 8 | BMPR2 | 2.62310676 |
| 9 | MAP3K4 | 2.58364699 |
| 10 | ITK | 2.50876198 |
| 11 | MAP3K12 | 2.48923594 |
| 12 | PLK2 | 2.42151224 |
| 13 | MAP2K7 | 2.35813885 |
| 14 | MINK1 | 2.34882087 |
| 15 | PNCK | 2.29194603 |
| 16 | NME1 | 2.17320052 |
| 17 | PTK2 | 2.15605689 |
| 18 | CASK | 2.09041321 |
| 19 | PTK2B | 2.06112338 |
| 20 | MAP2K4 | 2.01627347 |
| 21 | TESK2 | 1.93028231 |
| 22 | FES | 1.89940781 |
| 23 | FGR | 1.83805654 |
| 24 | GRK5 | 1.81966101 |
| 25 | DAPK1 | 1.81028194 |
| 26 | KDR | 1.77347609 |
| 27 | MAP3K13 | 1.70742715 |
| 28 | ARAF | 1.67333196 |
| 29 | SIK2 | 1.64891705 |
| 30 | TNIK | 1.62144667 |
| 31 | CAMK2B | 1.59779569 |
| 32 | MAPKAPK5 | 1.56149927 |
| 33 | KSR2 | 1.54311507 |
| 34 | VRK2 | 1.53365594 |
| 35 | KSR1 | 1.51849024 |
| 36 | STK16 | 1.49752603 |
| 37 | GRK6 | 1.49722569 |
| 38 | CAMK2A | 1.47813160 |
| 39 | DAPK2 | 1.46348768 |
| 40 | NTRK1 | 1.46012215 |
| 41 | NUAK1 | 1.35143311 |
| 42 | MAP2K2 | 1.29136968 |
| 43 | PRKCG | 1.27552389 |
| 44 | CDK5 | 1.26337813 |
| 45 | GRK7 | 1.22893309 |
| 46 | MAP4K2 | 1.21815690 |
| 47 | GRK1 | 1.21808330 |
| 48 | ERBB2 | 1.21629646 |
| 49 | BUB1 | 1.18655915 |
| 50 | NTRK2 | 1.16760286 |
| 51 | CAMK1G | 1.16595129 |
| 52 | MARK1 | 1.13351768 |
| 53 | PINK1 | 1.10567951 |
| 54 | RAF1 | 1.09320623 |
| 55 | BMPR1B | 1.07311945 |
| 56 | BTK | 1.03637688 |
| 57 | MKNK1 | 0.99491935 |
| 58 | PAK6 | 0.96321948 |
| 59 | FER | 0.93922262 |
| 60 | LIMK1 | 0.93662688 |
| 61 | DYRK1A | 0.92451691 |
| 62 | TAF1 | 0.90613888 |
| 63 | PRPF4B | 0.87912588 |
| 64 | CDK12 | 0.87276504 |
| 65 | PRKCI | 0.86492739 |
| 66 | MAPK13 | 0.84268492 |
| 67 | CAMK2D | 0.83046535 |
| 68 | CSF1R | 0.81013467 |
| 69 | PRKD3 | 0.76920677 |
| 70 | MAP3K7 | 0.73251903 |
| 71 | MKNK2 | 0.73141390 |
| 72 | BMX | 0.68317137 |
| 73 | CDK19 | 0.66945023 |
| 74 | PIK3CA | 0.64619219 |
| 75 | PRKCE | 0.64265140 |
| 76 | CAMK1 | 0.64159156 |
| 77 | ROCK2 | 0.63707291 |
| 78 | SGK1 | 0.63029795 |
| 79 | DMPK | 0.62714270 |
| 80 | MAP3K2 | 0.61817072 |
| 81 | STK38 | 0.59939027 |
| 82 | TNK2 | 0.59777685 |
| 83 | MAPK4 | 0.59040007 |
| 84 | CDK14 | 0.58387986 |
| 85 | PRKCQ | 0.58092285 |
| 86 | CDK18 | 0.57755949 |
| 87 | CAMK2G | 0.56756484 |
| 88 | MAP3K6 | 0.56603371 |
| 89 | PRKAA2 | 0.56327210 |
| 90 | BRSK1 | 0.56204325 |
| 91 | CAMKK1 | 0.55641613 |
| 92 | MARK2 | 0.55584166 |
| 93 | DYRK2 | 0.53861268 |
| 94 | KIT | 0.53676143 |
| 95 | CDK15 | 0.53494969 |
| 96 | SIK3 | 0.53044844 |
| 97 | PLK1 | 0.52133966 |
| 98 | TYRO3 | 0.51663544 |
| 99 | SYK | 0.50476970 |
| 100 | BCR | 0.49448704 |
| 101 | LATS2 | 0.49414058 |
| 102 | PAK3 | 0.48840704 |
| 103 | ROCK1 | 0.47072522 |
| 104 | CDK11A | 0.46592463 |
| 105 | OXSR1 | 0.46232563 |
| 106 | ADRBK1 | 0.45907786 |
| 107 | FYN | 0.44322262 |
| 108 | MET | 0.44067613 |
| 109 | CSNK1G3 | 0.43655743 |
| 110 | CAMK1D | 0.43462500 |
| 111 | MOS | 0.43096083 |
| 112 | MAPK12 | 0.42911755 |
| 113 | MAP3K1 | 0.42049463 |
| 114 | UHMK1 | 0.40670795 |
| 115 | MUSK | 0.40453084 |
| 116 | CDK4 | 0.40338874 |
| 117 | LMTK2 | 0.39848620 |
| 118 | MAPK10 | 0.39764044 |
| 119 | PRKACA | 0.39751396 |
| 120 | NEK6 | 0.39562299 |
| 121 | DAPK3 | 0.39377131 |
| 122 | IKBKE | 0.38618256 |
| 123 | PDK1 | 0.37784271 |
| 124 | CAMK4 | 0.37470141 |
| 125 | BCKDK | 0.37439308 |
| 126 | IGF1R | 0.37073390 |
| 127 | BRAF | 0.36540590 |
| 128 | PRKCZ | 0.36513933 |
| 129 | STK11 | 0.36390114 |
| 130 | STK38L | 0.35885517 |
| 131 | PDPK1 | 0.35778760 |
| 132 | PRKCA | 0.34399756 |
| 133 | MAP2K1 | 0.32707610 |
| 134 | CSNK1E | 0.31219802 |
| 135 | RPS6KA3 | 0.30688576 |
| 136 | ADRBK2 | 0.26705918 |
| 137 | CSNK1G2 | 0.25236710 |
| 138 | PRKCB | 0.25177743 |
| 139 | ABL2 | 0.23248950 |
| 140 | STK39 | 0.22942736 |
| 141 | SGK223 | 0.22928523 |
| 142 | SGK494 | 0.22928523 |
| 143 | DDR2 | 0.22441217 |
| 144 | CDK3 | 0.22435996 |
| 145 | CAMKK2 | 0.21792053 |
| 146 | RET | 0.21717235 |
| 147 | PRKG1 | 0.20054384 |
| 148 | CSNK1A1 | 0.19668201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.89411851 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 3.56182113 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.14969094 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.90746450 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.86742146 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.85440281 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63811582 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.58436887 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53400107 |
| 10 | Salivary secretion_Homo sapiens_hsa04970 | 2.45497821 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 2.30249525 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.24755889 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.23464143 |
| 14 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10361911 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 2.07737943 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 2.04721640 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.04673685 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.92663466 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.91844188 |
| 20 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.91210039 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.85935165 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85023428 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.84238840 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.83411961 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77095154 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.76717937 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73870565 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71946792 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69883037 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.66086176 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.57057818 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.54564727 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.52959461 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.52475868 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49614316 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48542383 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.48058009 |
| 38 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.45198583 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43758188 |
| 40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.40729171 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37498902 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 1.35522509 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32955565 |
| 44 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.30540638 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29728155 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29440626 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27752414 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.27009342 |
| 49 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25487018 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24942306 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24037299 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 1.20356721 |
| 53 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18831445 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 1.17439666 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.16636742 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 1.16482244 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15899715 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15782999 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12044599 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11904874 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.11489735 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 1.09093479 |
| 63 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.07701870 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05007749 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04286922 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.04246190 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03236459 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01773180 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.01471829 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01147795 |
| 71 | Glioma_Homo sapiens_hsa05214 | 1.00258935 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96556154 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95893228 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.95858877 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93670910 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92896227 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92752979 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91843215 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.91667328 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.89730268 |
| 81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86273246 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.85880639 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85645583 |
| 84 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.85371434 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85329699 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84486887 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.84009212 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83005848 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80690854 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79169419 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78953633 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71143799 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70168713 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69632267 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69357266 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69071597 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67200750 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66868987 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66573614 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66473685 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65965538 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65957313 |
| 103 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64883941 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63833951 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63448246 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.58856779 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58422371 |
| 108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57487093 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54905639 |
| 110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54148689 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52862578 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52644459 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51914565 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49222476 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48889213 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48065862 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46047667 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44694883 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44085395 |
| 120 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41784783 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.41567703 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40734464 |
| 123 | RNA polymerase_Homo sapiens_hsa03020 | 0.40668788 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.39653499 |
| 125 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39499683 |
| 126 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39048805 |
| 127 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37100182 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36809001 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36369402 |
| 130 | Proteasome_Homo sapiens_hsa03050 | 0.36130326 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36055332 |
| 132 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34145784 |
| 133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34004818 |
| 134 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32419150 |
| 135 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32146191 |
| 136 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31048335 |
| 137 | Bile secretion_Homo sapiens_hsa04976 | 0.30811561 |
| 138 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28041413 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27913749 |
| 140 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25795877 |
| 141 | Salmonella infection_Homo sapiens_hsa05132 | 0.24816290 |
| 142 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.23453310 |
| 143 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.23065103 |
| 144 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.22909349 |
| 145 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22529833 |
| 146 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21953613 |
| 147 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21914691 |
| 148 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21307914 |
| 149 | Alcoholism_Homo sapiens_hsa05034 | 0.20949847 |
| 150 | Shigellosis_Homo sapiens_hsa05131 | 0.16932905 |
| 151 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15233611 |
| 152 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.14479606 |
| 153 | Tuberculosis_Homo sapiens_hsa05152 | 0.14114283 |
| 154 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.12871173 |

